Statistics
Publications
35
Citations
1.2K
H-Index
20
Active since
1982
Shingen Nakamura is an author at Tokushima University specializing in medicine, oncology, and multiple myeloma.
Publications per year
1982–2023
35
35
TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth
Kyoko Takeuchi, Masahiro Abe, Masahiro Hiasa et al. · PLoS ONE · 2010 · 136 citations · Full text
Medicine, Oncology, Pharmacology +12
Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells
Ayako Nakano, Daisuke Tsuji, Hirokazu Miki et al. · PLoS ONE · 2011 · 106 citations · Full text
Medicine, Oncology, Pharmacology +17
The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells
Junji Asano, Akitoshi Nakano, A Oda et al. · Leukemia · 2011 · 105 citations · Full text
Medicine, Cell Biology, Oncology +12
Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma
Masahiro Hiasa, Jumpei Teramachi, A Oda et al. · Leukemia · 2014 · 63 citations
Medicine, Cancer Biology, Oncology +14
1–5 of 35